The net loss for Intellia Therapeutics in 2024 amounted to some 519 million U.S. dollars. The statistic illustrates the net loss for Intellia between 2014 and 2024. Intellia is a biotech company that produces therapeutics using CRISPR technology.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Intellia Therapeutics, & U.S. Securities and Exchange Commission. (February 27, 2025). Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 24, 2026, from /statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics, und U.S. Securities and Exchange Commission. "Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars)." Chart. February 27, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 24, 2026. /statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics, U.S. Securities and Exchange Commission. (2025). Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 24, 2026. /statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics, and U.S. Securities and Exchange Commission. "Net Loss of Intellia Therapeutics from 2014 to 2024 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 27 Feb 2025, /statistics/1097484/net-loss-intellia-therapeutics/
Intellia Therapeutics & U.S. Securities and Exchange Commission, Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1097484/net-loss-intellia-therapeutics/ (last visited July 24, 2026)
Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars) [Graph], Intellia Therapeutics, & U.S. Securities and Exchange Commission, February 27, 2025. [Online]. Available: /statistics/1097484/net-loss-intellia-therapeutics/
